Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications

Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications

In this study, we examined the metabolic adaptations of a chemoresistant prostate cancer cell line in comparison to a sensitive cell line. We utilized prostate cancer LNCaP cells and subjected them to a stepwise increase in the antiandrogen 2-hydroxy-flutamide (FLU) concentration to generate a FLU-r...

Full description

Bibliographic Details
Main Authors:	José María Mora-Rodríguez, Belén G. Sánchez, Alba Sebastián-Martín, Alba Díaz-Yuste, Manuel Sánchez-Chapado, Ana María Palacín, Carlos Sánchez-Rodríguez, Alicia Bort, Inés Díaz-Laviada
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	International Journal of Molecular Sciences
Subjects:	LNCaP cells flutamide antiandrogens dormant cells phosphatidylcholine metabolism resistant prostate cancer
Online Access:	https://www.mdpi.com/1422-0067/24/21/15626

Similar Items

Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase
by: Belén G. Sánchez, et al.
Published: (2019-03-01)

The Natural Chemotherapeutic Capsaicin Activates AMPK through LKB1 Kinase and TRPV1 Receptors in Prostate Cancer Cells
by: Belén G. Sánchez, et al.
Published: (2022-01-01)

Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells
by: Xingchen Dai, et al.
Published: (2023-12-01)

Antiproliferative and apoptotic effects of pinocembrin in human prostate cancer cells
by: Zhenyu Chen, et al.
Published: (2013-05-01)

Morphologic and biochemical changes in male rat lung after surgical and pharmacological castration
by: M.S. Ojeda, et al.
Published: (2000-03-01)

Is Irisin an Anticarcinogenic Peptide?
by: Suat Tekin, et al.
Published: (2015-06-01)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
by: Ximing Li, et al.
Published: (2020-06-01)

Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study
by: Jin-Ge Zhao, et al.
Published: (2018-01-01)

KAT5 Negatively regulates the proliferation of prostate cancer LNCaP cells via the caspase 3-dependent apoptosis pathway
by: Chul-Hong Kim, et al.
Published: (2019-07-01)

Flutamide-induced hepatotoxicity: A case report
by: Omer M. Kassid, et al.
Published: (2022-06-01)

Ailanthone: a new potential drug for castration-resistant prostate cancer
by: Shihong Peng, et al.
Published: (2017-03-01)

Zeolite Nanoparticles Loaded with 2-Methoxystradiol as a Novel Drug Delivery System for the Prostate Cancer Therapy
by: Denisse Mena-Silva, et al.
Published: (2023-06-01)

miR-100-5p Downregulates mTOR to Suppress the Proliferation, Migration, and Invasion of Prostate Cancer Cells
by: Yun Ye, et al.
Published: (2020-12-01)

Effects of Apelin-13 on Human Prostate Cancer Lines [Insan Prostat Kanseri Hucre Serilerinde Apelin-13un Etkileri]
by: Suat Tekin, et al.
Published: (2014-09-01)

Prostatic Therapeutic Efficacy of LENILUTS<sup>®</sup>, a Novel Formulation with Multi-Active Principles
by: Erik Tedesco, et al.
Published: (2022-09-01)

Characterization of camptothecin by analytical methods and determination of anticancer potential against prostate cancer
by: Sunil T. Galatage, et al.
Published: (2021-05-01)

Fibroblast Growth Factor-1 Induced Promatrilysin Expression Through the Activation of Extracellular-regulated Kinases and STAT3
by: Thirupandiyur S. Udayakumar, et al.
Published: (2002-01-01)

Voltammetric study of ds-DNA–flutamide interaction at carbon paste electrode
by: Pradeep K. Brahman, et al.
Published: (2016-11-01)

Induction of Apoptosis and Growth Suppression by Homeobox Gene TGIFLX in Prostate Cancer Cell Line Lncap.
by: Zahra Rashvand, et al.
Published: (2013-11-01)

Retardation of Preputial Wound Healing in Rats with Hypospadias Induced by Flutamide
by: Yue Zhou, et al.
Published: (2020-02-01)

The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells
by: Reem T. Attia, et al.
Published: (2016-06-01)

In Vitro Pro-apoptotic and Anti-migratory Effects of Ficus deltoidea L. Plant Extracts on the Human Prostate Cancer Cell Lines PC3
by: Mohd M. M. Hanafi, et al.
Published: (2017-12-01)

Laminin-5 β3A Expression in LNCaP Human Prostate Carcinoma Cells Increases Cell Migration and Tumorigenicity
by: Robert Calaluce, et al.
Published: (2004-09-01)

Isolation and Structural Characterization of Bioactive Molecules on Prostate Cancer from Mayan Traditional Medicinal Plants
by: Rafael Sebastián Fort, et al.
Published: (2018-08-01)

The Effect of Flutamide on Ovulation Induction in PCOS Patients
by: Tahereh Madani, et al.
Published: (2012-04-01)

The high stability and selectivity of electrochemical sensor using low-cost diamond nanoparticles for the detection of anti-cancer drug flutamide in environmental samples
by: Baskaran, Nareshkumar, et al.
Published: (2024)

The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies
by: Jennifer EL Diaz, et al.
Published: (2020-09-01)

Title Changes in the Mineral Composition of Rat Femoral Bones Induced by Implantation of LNCaP Prostate Cancer Cells and Dietary Supplementation
by: Dorota Skrajnowska, et al.
Published: (2020-12-01)

Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer
by: Francesca Corsi, et al.
Published: (2022-01-01)

Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM1
by: Yanping Dai, et al.
Published: (2021-03-01)

Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells
by: Gargi Thakur, et al.
Published: (2019-07-01)

Coenzyme Q 10 Abrogates Flutamide-induced Hepatotoxicity in Albino Rats
by: Elias Adikwu, et al.
Published: (2019-10-01)

Distinct Redox Profiles of Selected Human Prostate Carcinoma Cell Lines: Implications for Rational Design of Redox Therapy
by: Luksana Chaiswing, et al.
Published: (2011-09-01)

Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity
by: Sander Bekeschus, et al.
Published: (2020-04-01)

A Mathematical Investigation of the Multiple Pathways to Recurrent Prostate Cancer: Comparison with Experimental Data
by: Trachette L. Jackson
Published: (2004-11-01)

Suppression of ANT2 by miR-137 Inhibits Prostate Tumorigenesis
by: Heyuan Zhang, et al.
Published: (2021-09-01)

Bioanalytical method development, validation and quantification of flutamide in spiked rat plasma by using high-performance liquid chromatography
by: Vidya Sabale, et al.
Published: (2023-08-01)

Comparison of changes in serum prostate specific antigen in prostate cancer patients treated either with flutamide or stilboestrol monotherapy
by: O F Otobo, et al.
Published: (2020-01-01)

Flutamide-induced alterations in transcriptional profiling of neonatal porcine ovaries
by: Katarzyna Knapczyk-Stwora, et al.
Published: (2019-04-01)

Comparison of Low-Dose Treatment of Isotretinoin and Flutamide Combined with Oral Erythromycin for Female Patients with Severe Acne
by: Hassan Adalatkhah, et al.
Published: (2021-10-01)